Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - CASH & EQUIVALENTS
Cash & Equivalents INZY - Inozyme Pharma, Inc.
34.6 M
LAST VALUE
21.80%
2 YEAR CAGR
-0.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR